NEW YORK, April 1 (Reuters) - Early-stage trials of an experimental Ebola vaccine, two in the United States and four in Africa and Europe, have found that it appears to be safe and triggered robust production of Ebola-fighting antibodies, scientists reported on Wednesday.
still look undervalued, including Merck MRK , Actavis ACT, and Baxter BAX ..... are well-positioned for growth. Merck MRK Despite some upcoming patent loses, we believe the market undervalues Merck 's strong pipeline, led by cancer
Merck MRK announced on Thursday that the New Jersey ..... purchases. We believe the ruling bodes well for Merck , and we are not changing our fair value ..... to a class-action suit. Furthermore, Merck can spread the cases out over several years
March 27 (Reuters) - European Medicines Agency: * EU medicines agency says recommends approval of Merck 's Gardasil 9
first mover in this space. They are followed closely by Merck ( MRK ). And we think, longer term, both Roche (ROG) and ..... early-stage assets. Of the companies I just mentioned, Merck is currently the most undervalued. It is currently trading
* Announces extension of ion channel research collaboration with Merck & Co., Inc.
CONAKRY/DAKAR, March 25 (Reuters) - Guinea started testing an experimental Ebola vaccine from Merck and NewLink Genetics on affected communities this week, in a move officials hope will accelerate the end of an epidemic first detected a year ago.
March 24 (Reuters) - Drugmaker Merck Inc said its board authorized an additional share repurchase of up to $10 billion of the company's common stock.
March 24 (Reuters) - Merck & Co Inc said on Tuesday that it would stop a large study of its Keytruda melanoma treatment early because an independent monitoring
March 24 (Reuters) - Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring